Clinical Trial Update: Mifepristone Induction for Fetal Demise [Phase 4]

View source ↗

Summary

A Phase 4 trial of mifepristone induction for intrauterine fetal demise was terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Death
• Intrauterine Fetal Demise

Drugs mentioned

• Mifepristone (mifepristone)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Intrauterine Fetal Demise, Fetal Death | Phase 4 | Status: TERMINATED | Results posted: 2021-02-18